Send feedback

MYO7A p.Arg873Trp

c.2617C>T · rs200454015 · VCV43187

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 12 submitters
AlphaMissense
ambiguous
0.395 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.137%, nfe)
Missense predictors
2/2 damaging
REVEL, SaProt · AlphaMissense no call
Conditions
5
Meniere disease

Computational evidence

Protein change
AlphaMissense0.395ambiguous
REVEL0.821moderately pathogenic-leaning
SaProtLLR -13.33damaging
⇒ REVEL and SaProt both call this damaging; AlphaMissense makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.1GERP -0.6, phastCons 1
Regional constrainto/e 0.95unconstrained · MANE · 84 kb · p 0.0065 · regional, not allelic
Overall
CADD25.9PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.137% European (non-Finnish) · 1,621/1,179,548 alleles
Filtering AF 0.132% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.13%
Overall 0.116% 1,871/1,611,950 alleles · rare exomes 1,743/1,459,682 · genomes 128/152,268 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.25% 399
European (non-Finnish)grpmax 0.137% 728
Remaining individualsnot grpmax-eligible 0.0929% 1,077
African / African-American 0.0307% 3,262
Ashkenazi Jewishnot grpmax-eligible 0.00676% 14,800
Admixed American 0.00668% 14,979
East Asian 0.00446% 22,425
South Asian 0.0044% 22,721

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MYO7A
Protein
p.Arg873Trp
Coding
c.2617C>T
MANE Select
NM_000260
dbSNP
rs200454015
Type
single nucleotide variant
Location
chr11:77180404 (GRCh38)
Gene constraint
LOEUF 0.995 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 77.73 · 1 PDB
Residue 873
the 'sah' region
Full MYO7A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myo7a-p-arg873trp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown